InvaGen Pharmaceuticals Inc., affiliated to Cipla Ltd., is recalling one lot of Vigabatrin for Oral Solution, USP, citing leakage issues, according to the U.S Food and Drug Administration or FDA.
Carisma Therapeutics Inc. (CARM) announced the clearance of Investigational New Drug application by the FDA for CT-0525 in treatment of solid tumors that overexpress human epidermal growth factor receptor 2.
Consumer confidence survey results from Germany and France are due on Tuesday, headlining a busy day for the European economic news. At 2.00 am ET, the market research group Gfk is scheduled to issue Germany's consumer confidence survey results.
Swiss drug major Novartis AG is recalling two lots of its Sandimmune Oral Solution (cyclosporine oral solution, USP), 100 mg/mL at the consumer level in the US, the U.
Greencore Group plc (GNC.L) reported that its fiscal 2023 profit before taxation increased to 45.2 million pounds from 39.8 million pounds, last year, driven by higher operating profit and lower exceptional items offset by higher finance costs.